List of Tables

    Table 1. Global Antibody-drug Conjugate for Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Hematological Malignancies Drugs

    Table 3. Key Players of Solid Tumor Drugs

    Table 4. Global Antibody-drug Conjugate for Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 5. Global Antibody-drug Conjugate for Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Antibody-drug Conjugate for Cancer Market Size by Region (2019-2024) & (US$ Million)

    Table 7. Global Antibody-drug Conjugate for Cancer Market Share by Region (2019-2024)

    Table 8. Global Antibody-drug Conjugate for Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 9. Global Antibody-drug Conjugate for Cancer Market Share by Region (2025-2030)

    Table 10. Antibody-drug Conjugate for Cancer Market Trends

    Table 11. Antibody-drug Conjugate for Cancer Market Drivers

    Table 12. Antibody-drug Conjugate for Cancer Market Challenges

    Table 13. Antibody-drug Conjugate for Cancer Market Restraints

    Table 14. Global Antibody-drug Conjugate for Cancer Revenue by Players (2019-2024) & (US$ Million)

    Table 15. Global Antibody-drug Conjugate for Cancer Market Share by Players (2019-2024)

    Table 16. Global Top Antibody-drug Conjugate for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugate for Cancer as of 2023)

    Table 17. Ranking of Global Top Antibody-drug Conjugate for Cancer Companies by Revenue (US$ Million) in 2023

    Table 18. Global 5 Largest Players Market Share by Antibody-drug Conjugate for Cancer Revenue (CR5 and HHI) & (2019-2024)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Antibody-drug Conjugate for Cancer Product Solution and Service

    Table 21. Date of Enter into Antibody-drug Conjugate for Cancer Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Antibody-drug Conjugate for Cancer Market Size by Type (2019-2024) & (US$ Million)

    Table 24. Global Antibody-drug Conjugate for Cancer Revenue Market Share by Type (2019-2024)

    Table 25. Global Antibody-drug Conjugate for Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 26. Global Antibody-drug Conjugate for Cancer Revenue Market Share by Type (2025-2030)

    Table 27. Global Antibody-drug Conjugate for Cancer Market Size by Application (2019-2024) & (US$ Million)

    Table 28. Global Antibody-drug Conjugate for Cancer Revenue Market Share by Application (2019-2024)

    Table 29. Global Antibody-drug Conjugate for Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 30. Global Antibody-drug Conjugate for Cancer Revenue Market Share by Application (2025-2030)

    Table 31. North America Antibody-drug Conjugate for Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 32. North America Antibody-drug Conjugate for Cancer Market Size by Country (2019-2024) & (US$ Million)

    Table 33. North America Antibody-drug Conjugate for Cancer Market Size by Country (2025-2030) & (US$ Million)

    Table 34. Europe Antibody-drug Conjugate for Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 35. Europe Antibody-drug Conjugate for Cancer Market Size by Country (2019-2024) & (US$ Million)

    Table 36. Europe Antibody-drug Conjugate for Cancer Market Size by Country (2025-2030) & (US$ Million)

    Table 37. Asia-Pacific Antibody-drug Conjugate for Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 38. Asia-Pacific Antibody-drug Conjugate for Cancer Market Size by Region (2019-2024) & (US$ Million)

    Table 39. Asia-Pacific Antibody-drug Conjugate for Cancer Market Size by Region (2025-2030) & (US$ Million)

    Table 40. Latin America Antibody-drug Conjugate for Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 41. Latin America Antibody-drug Conjugate for Cancer Market Size by Country (2019-2024) & (US$ Million)

    Table 42. Latin America Antibody-drug Conjugate for Cancer Market Size by Country (2025-2030) & (US$ Million)

    Table 43. Middle East & Africa Antibody-drug Conjugate for Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 44. Middle East & Africa Antibody-drug Conjugate for Cancer Market Size by Country (2019-2024) & (US$ Million)

    Table 45. Middle East & Africa Antibody-drug Conjugate for Cancer Market Size by Country (2025-2030) & (US$ Million)

    Table 46. Gilead Sciences Company Detail

    Table 47. Gilead Sciences Business Overview

    Table 48. Gilead Sciences Antibody-drug Conjugate for Cancer Product

    Table 49. Gilead Sciences Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 50. Gilead Sciences Recent Development

    Table 51. Roche Company Detail

    Table 52. Roche Business Overview

    Table 53. Roche Antibody-drug Conjugate for Cancer Product

    Table 54. Roche Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 55. Roche Recent Development

    Table 56. Pfizer Company Detail

    Table 57. Pfizer Business Overview

    Table 58. Pfizer Antibody-drug Conjugate for Cancer Product

    Table 59. Pfizer Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 60. Pfizer Recent Development

    Table 61. Takeda Company Detail

    Table 62. Takeda Business Overview

    Table 63. Takeda Antibody-drug Conjugate for Cancer Product

    Table 64. Takeda Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 65. Takeda Recent Development

    Table 66. Seagen Company Detail

    Table 67. Seagen Business Overview

    Table 68. Seagen Antibody-drug Conjugate for Cancer Product

    Table 69. Seagen Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 70. Seagen Recent Development

    Table 71. Innate Pharma Company Detail

    Table 72. Innate Pharma Business Overview

    Table 73. Innate Pharma Antibody-drug Conjugate for Cancer Product

    Table 74. Innate Pharma Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 75. Innate Pharma Recent Development

    Table 76. AstraZeneca Company Detail

    Table 77. AstraZeneca Business Overview

    Table 78. AstraZeneca Antibody-drug Conjugate for Cancer Product

    Table 79. AstraZeneca Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 80. AstraZeneca Recent Development

    Table 81. GSK Company Detail

    Table 82. GSK Business Overview

    Table 83. GSK Antibody-drug Conjugate for Cancer Product

    Table 84. GSK Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 85. GSK Recent Development

    Table 86. Rakuten Medical Company Detail

    Table 87. Rakuten Medical Business Overview

    Table 88. Rakuten Medical Antibody-drug Conjugate for Cancer Product

    Table 89. Rakuten Medical Revenue in Antibody-drug Conjugate for Cancer Business (2019-2024) & (US$ Million)

    Table 90. Rakuten Medical Recent Development

    Table 91. Research Programs/Design for This Report

    Table 92. Key Data Information from Secondary Sources

    Table 93. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Antibody-drug Conjugate for Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Antibody-drug Conjugate for Cancer Market Share by Type: 2023 VS 2030

    Figure 3. Hematological Malignancies Drugs Features

    Figure 4. Solid Tumor Drugs Features

    Figure 5. Global Antibody-drug Conjugate for Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 6. Global Antibody-drug Conjugate for Cancer Market Share by Application: 2023 VS 2030

    Figure 7. Hospital Case Studies

    Figure 8. Pharmacy Case Studies

    Figure 9. Other Case Studies

    Figure 10. Antibody-drug Conjugate for Cancer Report Years Considered

    Figure 11. Global Antibody-drug Conjugate for Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 12. Global Antibody-drug Conjugate for Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 13. Global Antibody-drug Conjugate for Cancer Market Share by Region: 2023 VS 2030

    Figure 14. Global Antibody-drug Conjugate for Cancer Market Share by Players in 2023

    Figure 15. Global Top Antibody-drug Conjugate for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugate for Cancer as of 2023)

    Figure 16. The Top 10 and 5 Players Market Share by Antibody-drug Conjugate for Cancer Revenue in 2023

    Figure 17. North America Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 18. North America Antibody-drug Conjugate for Cancer Market Share by Country (2019-2030)

    Figure 19. United States Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 20. Canada Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Europe Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Antibody-drug Conjugate for Cancer Market Share by Country (2019-2030)

    Figure 23. Germany Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 24. France Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. U.K. Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. Italy Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Russia Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Nordic Countries Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Asia-Pacific Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Antibody-drug Conjugate for Cancer Market Share by Region (2019-2030)

    Figure 31. China Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 32. Japan Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. South Korea Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. Southeast Asia Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. India Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. Australia Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Latin America Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Antibody-drug Conjugate for Cancer Market Share by Country (2019-2030)

    Figure 39. Mexico Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 40. Brazil Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Middle East & Africa Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Antibody-drug Conjugate for Cancer Market Share by Country (2019-2030)

    Figure 43. Turkey Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 44. Saudi Arabia Antibody-drug Conjugate for Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Gilead Sciences Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 46. Roche Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 47. Pfizer Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 48. Takeda Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 49. Seagen Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 50. Innate Pharma Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 51. AstraZeneca Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 52. GSK Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 53. Rakuten Medical Revenue Growth Rate in Antibody-drug Conjugate for Cancer Business (2019-2024)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed